Futuximab Uses, Dosage, Side Effects and more
Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid Tumors).
| Trade Name | Futuximab |
| Generic | Futuximab |
| Futuximab Other Names | Futuximab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
